share_log

Aslan Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-TANG CAPITAL PARTNERS, LP(5.4%),Tang Capital Management, LLC(5.4%), etc.

Aslan Pharmaceuticals | SC 13G:超过5%持股股东披露文件-TANG CAPITAL PARTNERS, LP(5.4%),Tang Capital Management, LLC(5.4%)等

美股sec公告 ·  2022/04/21 16:00
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息